Skip to main content
logo
Turn Therapeutics Inc. (TTRX)
NASDAQ: TTRX · Real-Time Price · USD
4.820
+0.080 (1.69%)
Jan 15, 2026, 4:00 PM EST - Market closed

Company Description

Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye.

The company's delivery technology penetrates the skin and nails and reduces antibiotic resistance through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses.

The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025.

Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.

Turn Therapeutics Inc.
Turn Therapeutics logo
CountryUnited States
Founded2015
IndustryBiotechnology
SectorHealthcare
CEOBradley Burnam

Contact Details

Address:
250 N Westlake Blvd
Westlake Village, California 91362
United States
Phone818 546 4011
Websiteturntherapeutics.com

Stock Details

Ticker SymbolTTRX
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code2023016
CUSIP Number90021W105
ISIN NumberUS90021W1053
Employer ID32-0456090
SIC Code2834

Key Executives

NamePosition
Dr. Neilesh Shailesh Ghodadra M.D.Chief Medical Officer and Director
Zuraiz ChaudharyInterim Chief Financial Officer, Vice President of Finance and Chief Accounting Officer
Mohammed ZubairController

Latest SEC Filings

DateTypeTitle
Jan 12, 20268-KCurrent Report
Jan 7, 20268-KCurrent Report
Nov 17, 2025424B3Prospectus
Nov 17, 2025424B3Prospectus
Nov 13, 202510-QQuarterly Report
Nov 13, 20258-KCurrent Report
Nov 12, 20258-KCurrent Report
Nov 4, 20258-KCurrent Report
Oct 30, 20258-KCurrent Report
Oct 29, 2025424B5Filing
View All SEC Filings